A1AIA
primidone
| Created: | 2024-03-15 |
| Last modified: | 2025-01-22 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 30 |
| Chiral Atom Count | 0 |
| Bond Count | 31 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | primidone |
| Synonyms | 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione |
| Systematic Name (OpenEye OEToolkits) | 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione |
| Formula | C12 H14 N2 O2 |
| Molecular Weight | 218.252 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | CCC1(C(=O)NCNC1=O)c1ccccc1 |
| SMILES | CACTVS | 3.385 | CCC1(C(=O)NCNC1=O)c2ccccc2 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CCC1(C(=O)NCNC1=O)c2ccccc2 |
| Canonical SMILES | CACTVS | 3.385 | CCC1(C(=O)NCNC1=O)c2ccccc2 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCC1(C(=O)NCNC1=O)c2ccccc2 |
| InChI | InChI | 1.06 | InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) |
| InChIKey | InChI | 1.06 | DQMZLTXERSFNPB-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00794 |
|---|---|
| Name | Primidone |
| Groups |
|
| Description | Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures.[L11112] Primidone was developed by J Yule Bogue and H C Carrington in 1949.[A189522] Primidone was granted FDA Approval on 8 March 1954.[L11112] |
| Synonyms |
|
| Brand Names |
|
| Indication | Primidone is commonly indicated for the management of grand mal, psychomotor, and focal epileptic seizures.[L4645,L11112] In addition, it has also been studied and utilized as an effective management of essential tremor.[A39414,A39415,L4645] |
| Categories |
|
| ATC-Code |
|
| CAS number | 125-33-7 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Gamma-aminobutyric acid receptor subunit alpha-2 | MKTKLNIYNMQFLLFVFLVWDPARLVLANIQEDEAKNNITIFTRILDRLL... | unknown | potentiator |
| Gamma-aminobutyric acid receptor subunit alpha-3 | MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSP... | unknown | potentiator |
| Gamma-aminobutyric acid receptor subunit alpha-4 | MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTR... | unknown | potentiator |
| Gamma-aminobutyric acid receptor subunit alpha-5 | MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFT... | unknown | potentiator |
| Gamma-aminobutyric acid receptor subunit alpha-6 | MASSLPWLCIILWLENALGKLEVEGNFYSENVSRILDNLLEGYDNRLRPG... | unknown | potentiator |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL856 |
| PubChem | 4909 |
| ChEMBL | CHEMBL856 |
| ChEBI | CHEBI:8412 |
| CCDC/CSD | EPHPMO |














